# Long-Term Effects of Sucontral(TM) on Mild and Moderate Cases of Diabetes Mellitus (Type 2)

> **NCT00315718** · PHASE3 · COMPLETED · sponsor: **Harras Pharma Curarina GmbH** · enrollment: 10 (—)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Extract from Hintonia latiflora bark

## Key facts

- **NCT ID:** NCT00315718
- **Lead sponsor:** Harras Pharma Curarina GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-06
- **Primary completion:** —
- **Final completion:** 2005-06
- **Target enrollment:** 10 (—)
- **Last updated:** 2006-04-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00315718

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00315718, "Long-Term Effects of Sucontral(TM) on Mild and Moderate Cases of Diabetes Mellitus (Type 2)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00315718. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*